Malaria Drug Slows Pancreatic Cancer Growth in Mouse Models

Dana-Farber Cancer Institute scientists report they have used hydroxychloroquine, a drug routinely prescribed for malaria and rheumatoid arthritis, to shrink or slow the growth of notoriously resistant pancreatic tumors in mice.
—Dana-Farber Cancer Institute